← Leaderboards
Sarah Hartz
Washington University
$6,766,844
Attributed
$9,375,913
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2012–25$2.5M$1.9M$1.3M$625K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,375,913 · 6
By mechanism
R01$7,186,888 · 3
U10$1,085,163 · 1
K08$687,290 · 1
R21$416,572 · 1
Top collaborators
- Jessica Mozersky8 shared
Most similar at Washington University
Same institution · by research overlap
- Laura Jean Bierut$29,352,289
- Joel Gelernter$58,128,052
- Howard J Edenberg$27,305,449
- Joan L Luby$32,934,481
- Christopher Daniel Smyser$22,079,913
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposGeneticDesignParticipantBrainSamplingS DiseasePre-ClinicalDementiaResearch PersonnelLongitudinal StudiesS Disease RiskCohortAfrican AmericanInsightComorbidityMethodologyBaseGenotypeEvaluationEventInnovationFoundationsAffect
Grant awards (22)
Returning AD biomarker Results to Community Dwelling Older Adults: Testing Modalities and Impact$674,607
R01 · FY2025 · AG
Data Management Core$525,156
U10 · FY2025 · AA · contact PI
Returning AD biomarker Results to Community Dwelling Older Adults: Testing Modalities and Impact$715,539
R01 · FY2024 · AG
Returning Research Results that Indicate Risk of Alzheimer Disease to Healthy Participants in Longitudinal Studies$579,754
R01 · FY2024 · AG · contact PI
Data Management Core$560,007
U10 · FY2024 · AA · contact PI
Investigating the longitudinal relationship between alcohol use, neurophysiological functioning, and Alzheimer disease biomarkers in the Collaborative Study on the Genetics of Alcoholism$393,750
R01 · FY2024 · AA · contact PI
Returning Research Results that Indicate Risk of Alzheimer Disease to Healthy Participants in Longitudinal Studies$706,098
R01 · FY2023 · AG · contact PI
Investigating the longitudinal relationship between alcohol use, neurophysiological functioning, and Alzheimer disease biomarkers in the Collaborative Study on the Genetics of Alcoholism$393,750
R01 · FY2023 · AA · contact PI
Returning Research Results that Indicate Risk of Alzheimer Disease to Healthy Participants in Longitudinal Studies$721,414
R01 · FY2022 · AG · contact PI
Investigating the longitudinal relationship between alcohol use, neurophysiological functioning, and Alzheimer disease biomarkers in the Collaborative Study on the Genetics of Alcoholism$393,750
R01 · FY2022 · AA · contact PI
Returning Research Results that Indicate Risk of Alzheimer Disease to Healthy Participants in Longitudinal Studies$393,575
R01 · FY2022 · AG · contact PI
Returning Research Results that Indicate Risk of Alzheimer Disease to Healthy Participants in Longitudinal Studies$716,020
R01 · FY2021 · AG · contact PI
Investigating the longitudinal relationship between alcohol use, neurophysiological functioning, and Alzheimer disease biomarkers in the Collaborative Study on the Genetics of Alcoholism$393,750
R01 · FY2021 · AA · contact PI
Returning Research Results that Indicate Risk of Alzheimer Disease to Healthy Participants in Longitudinal Studies$711,131
R01 · FY2020 · AG · contact PI
Investigating the longitudinal relationship between alcohol use, neurophysiological functioning, and Alzheimer disease biomarkers in the Collaborative Study on the Genetics of Alcoholism$393,750
R01 · FY2020 · AA · contact PI
THE SHARED GENETICS OF ALCOHOL-RELATED DISORDERS AND SCHIZOPHRENIA$221,614
R21 · FY2018 · AA · contact PI
THE SHARED GENETICS OF ALCOHOL-RELATED DISORDERS AND SCHIZOPHRENIA$194,958
R21 · FY2017 · AA · contact PI
Novel Use of Gwas for Improved Understanding of Nicotine Dependence$137,458
K08 · FY2016 · DA · contact PI
Novel Use of Gwas for Improved Understanding of Nicotine Dependence$137,458
K08 · FY2015 · DA · contact PI
Novel Use of Gwas for Improved Understanding of Nicotine Dependence$137,458
K08 · FY2014 · DA · contact PI
Novel Use of Gwas for Improved Understanding of Nicotine Dependence$137,458
K08 · FY2013 · DA · contact PI
Novel Use of Gwas for Improved Understanding of Nicotine Dependence$137,458
K08 · FY2012 · DA · contact PI